See Article: https://evtoday.com/articles/2021-oct/interventional-oncology-fast-forward-to-the-future?c4src=current:feed Histotripsy is one such therapy that has the promise of changing cancer care. It is a completely noninvasive approach akin to radiation oncology without the toxicity due to radiation and to high-intensity focused ultrasound without the problems inherent in thermal deposition in tissue with existing ablative therapies.6 The cellular destruction caused by histotripsy […]
Monthly Archives: October 2021
HistoSonics Receives FDA “Breakthrough Device Designation” for Novel Sonic Beam Therapy Breakthrough status for new histotripsy targeted liver therapy will help provide timely access to non-invasive liver treatment MINNEAPOLIS, Oct. 18, 2021 /PRNewswire/ — HistoSonics, (www.histosonics.com), the developer and manufacturer of a non-invasive platform and novel sonic beam therapy called histotripsy, announced today that the U.S. Food and […]